US Patent Issued to The Government of the United States of America, as represented by the Secretary of the Navy on March 31 for "Quantum dot conjugated virus spike protein for cell-based bio-sensing systems and drug screening" (Virginia, Maryland Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,961, issued on March 31, was assigned to The Government of the United States of America, as represented by the Secretary of the Navy (Arlington, Va.).

"Quantum dot conjugated virus spike protein for cell-based bio-sensing systems and drug screening" was invented by Eunkeu Oh (Alexandria, Va.), Kimihiro Susumu (Alexandria, Va.), Mason A. Wolak (Alexandria, Va.) and Kirill Gorshkov (Gaithersburg, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Quantum dots conjugated to SARS-CoV-2 Spike protein receptor binding domain (RBD) interact with gold nanoparticles bound to angiotensin converting enzyme 2 (ACE2) and thus undergo energy transfer. This energ...